DPIIT recognised startup Government of India
Startup India
Tzana Pharmaceuticals Private Limited - electrnoics in Bangalore, Karnataka, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹41.02 Lakh
▲ 74% YoY
Net loss · FY 2025
₹13.88 Lakh
Net margin -33.8%
EBITDA · FY 2025
-₹13.88 Lakh
EBITDA margin -33.8%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
9 yrs
Est. 2017
Directors on board
3
As per MCA filings
Active GSTINs
2
GST registered
About Tzana Pharmaceuticals Private Limited
Data last updated:
Tzana Pharmaceuticals Private Limited is a private limited company based in Bangalore, Karnataka, India, recognised as a startup by DPIIT. It operates in the repair services segment of the electronics sector. It was incorporated on 07 June 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U52601KA2017PTC103665. Its GSTIN is 29AAGCT2928P1ZL (Karnataka). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Abdulbijur Vallarkodath and Chundanveetil Aboobacker Abdul Najeeb.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No. 39 Ngef Lane Indranagar First Stage, Bangalore, Karnataka, India – 560038.
As per the financials filed for FY 2025, the company reported a revenue of ₹41.02 Lakh, a growth of 74% compared to the previous year. For the same year it recorded a net loss of ₹13.88 Lakh (net margin -33.8%) and EBITDA of -₹13.88 Lakh (EBITDA margin -33.8%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 3% over five years.
The company is associated with 2 brands: Zana Organics and Tzana.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website tzana.co.in.
Company details
CIN U52601KA2017PTC103665
Registration Number 103665
Incorporation Date 07 June 2017
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 29 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
DPIIT Recognition Recognised Startup
Key People
Abdulbijur Vallarkodath Director Farzana Bijur Abdul Additional Director Chundanveetil Aboobacker Abdul Najeeb Director Recognitions & Rankings of Tzana Pharmaceuticals
Contact details
Tzana Pharmaceuticals Private Limited's registered office is in Bangalore, Karnataka. Its website is tzana.co.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressNo. 39 Ngef Lane Indranagar First Stage, Bangalore, Karnataka, India – 560038
- IndustryElectrnoics, Repair Services
To see the full contact details of Tzana Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Tzana Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Tzana Pharmaceuticals operates two associated brands: Zana Organics and Tzana. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Online seller of organic soaps, vitamins, and skin care products for health and wellness. | zanaorganics.com | |
| Pharmaceutical manufacturing and distribution of quality medicines in India. | tzana.co.in |
Business activity
The main business activity of Tzana Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Tzana Pharmaceuticals Private Limited, buy the company report.
Financials of Tzana Pharmaceuticals Private Limited
FY 2025 filings availableTzana Pharmaceuticals Private Limited reported revenue of ₹41.02 Lakh (up 74% YoY) for FY 2025.
Revenue · FY 2025
₹41.02 Lakh ▲ 74%
Net loss · FY 2025
₹13.88 Lakh margin -33.8%
EBITDA · FY 2025
-₹13.88 Lakh margin -33.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 74%
3 years · compounded
▲ 1%
5 years · compounded
▲ 3%
EBITDA CAGR growth
1 year
▼ 6%
3 years · compounded
▲ 4%
5 years · compounded
▼ 172%
Revenue has grown at a compounded annual rate (CAGR) of 3% over five years, including 74% growth in the latest year. EBITDA fell 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹13.88 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹13.88 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -33.8% | ||||
| Net Profit Margin | -33.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Tzana Pharmaceuticals Private Limited, buy the company report.
Board of directors of Tzana Pharmaceuticals Private Limited
Tzana Pharmaceuticals has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Abdulbijur Vallarkodath Also directs: Avallark Services LLP, Turingfly LLP | Director | 07 Jun 2017 | 9 Years 4 Months | Current |
| Farzana Bijur Abdul Also directs: Avallark Services LLP | Additional Director | 12 Jan 2018 | 8 Years 9 Months | Current |
| Chundanveetil Aboobacker Abdul Najeeb | Director | 07 Jun 2017 | 9 Years 4 Months | Current |
Peer comparison
Tzana Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sarv Shakti Ayurvedic Pharmaceuticals Private Limited | ₹41.25 Lakh (FY 2016) | 13.0% | Amritsar, Punjab, India | |||
| Waxberry Pharmaceuticals Private Limited | ₹41.07 Lakh (FY 2025) | 4.0% | Jodhpur, Rajasthan, India | |||
| Tzana Pharmaceuticals Private Limitedthis company | ₹41.02 Lakh (FY 2025) | -₹13.88 Lakh | -33.8% | 74.0% | Bangalore, Karnataka, India | |
| Dayton Pharmaceuticals Private Limited | ₹40.78 Lakh (FY 2024) | 32.0% | Ghaziabad, Uttar Pradesh, India |
To see the full peer comparison of Tzana Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Tzana Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Tzana Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Tzana Pharmaceuticals has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAGCT2928P1ZL | Karnataka | Active | 04 Feb 2018 |
| 32AAGCT2928P1ZY | Kerala | Active | 07 Jul 2017 |
To see the full GST registrations and return filing status of Tzana Pharmaceuticals Private Limited, buy the company report.
Recent activity
Tzana Pharmaceuticals Private Limited has 3 board changes on record since 2017: 3 appointments. The latest: Farzana Bijur Abdul was appointed as Additional Director on 12 Jan 2018.
AGM
Tzana Pharmaceuticals Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Filing
Tzana Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore.
Appointed
Farzana Bijur Abdul was appointed as Additional Director.
Appointed
Abdulbijur Vallarkodath was appointed as Director.
Appointed
Chundanveetil Aboobacker Abdul Najeeb was appointed as Director.
Incorporation
07 Jun 2017
Tzana Pharmaceuticals Private Limited was registered on 07 Jun 2017 with Roc Bangalore & aged 9 years 4 months as per MCA records.
Frequently asked questions
Tzana Pharmaceuticals is an active private limited company based in Bangalore, Karnataka, India. The company works in repair services, within the electronics industry. It was incorporated on 07 June 2017 (9+ years old) and is registered under CIN U52601KA2017PTC103665.
Tzana Pharmaceuticals has 3 current directors:
- Abdulbijur Vallarkodath - Director
- Farzana Bijur Abdul - Additional Director
- Chundanveetil Aboobacker Abdul Najeeb - Director
The latest financial statements of Tzana Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Tzana Pharmaceuticals is 29AAGCT2928P1ZL, registered in Karnataka. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 32AAGCT2928P1ZY (Kerala).
The CIN (Corporate Identification Number) of Tzana Pharmaceuticals is U52601KA2017PTC103665. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Tzana Pharmaceuticals was incorporated on 07 June 2017, making it 9+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Tzana Pharmaceuticals by revenue are Sarv Shakti Ayurvedic Pharmaceuticals Private Limited, Waxberry Pharmaceuticals Private Limited, Dayton Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Farzana Bijur Abdul was appointed as Additional Director on 12 Jan 2018. Abdulbijur Vallarkodath was appointed as Director on 07 Jun 2017. Chundanveetil Aboobacker Abdul Najeeb was appointed as Director on 07 Jun 2017.
Yes, Tzana Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Tzana Pharmaceuticals can be reached through the website tzana.co.in. Its registered office is in Bangalore, Karnataka, India.
The registered office of Tzana Pharmaceuticals is at No. 39 Ngef Lane Indranagar First Stage, Bangalore, Karnataka, India – 560038.